M. Siamatu

发表

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters

Y. Kawaoka, P. Halfmann, Mark G. Lewis, 2022, bioRxiv.

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

D. Barouch, Jingyou Yu, A. Chandrashekar, 2022, The New England journal of medicine.

Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex

R. Baric, Bette Korber, K. Wagh, 2022, npj Vaccines.

Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques

R. Siliciano, G. Alter, D. Barouch, 2021, Nature Communications.

Vaccine protection against the SARS-CoV-2 Omicron variant in macaques

A. Boon, H. Andersen, D. Barouch, 2022, Cell.

Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques

A. Boon, H. Andersen, D. Barouch, 2022, bioRxiv.

Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts

L. Madoff, D. Barouch, A. Chandrashekar, 2021, medRxiv.

Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

D. Barouch, Jingyou Yu, A. Chandrashekar, 2022, medRxiv.

Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant

L. Madoff, D. Barouch, Jingyou Yu, 2022, Science Translational Medicine.

SARS-CoV-2 RBD dimers elicit response comparable to VLPs in mice

Neil C. Dalvie, Sergio A. Rodriguez-Aponte, L. Tostanoski, 2023, Research Square.